SCHEMBL7524933

SCHEMBL7524933

CCCCCCCCCCCCCCCC(O)=S.CCCCCCCCCCCCCCCC(O)=S

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.57
CES1 P23141 4/20 0.57
GPR84 Q9NQS5 7/20 0.55
PPARG P37231 7/20 0.55
PPARD Q03181 7/20 0.55
PPARA Q07869 7/20 0.55
HDAC11 Q96DB2 5/20 0.55
TSHR P16473 4/20 0.55
PTPN1 P18031 3/20 0.55
ALDH1A1 P00352 2/20 0.55
TLR2 O60603 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
FABP4 P15090 2/20 0.55
SLC22A6 Q4U2R8 1/20 0.55
SLC22A8 Q8TCC7 1/20 0.55
MEN1 O00255 1/20 0.55
ESR1 P03372 1/20 0.55
ALOX15 P16050 1/20 0.55
PDE4A P27815 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368594 1.00
SCHEMBL3652374 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD
SCHEMBL4814086 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD
SCHEMBL23892 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD
SCHEMBL372778 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD
SCHEMBL181532 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD
SCHEMBL4649868 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD
SCHEMBL1815133 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD
SCHEMBL1604061 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD
SCHEMBL7743611 1.00 CES2 (0.57) CES2CES1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1180013-A1 LOCAL DRUG DELIVERY BIOCOMPATIBLES LTD. (GB) 2002-02-20 EP disclosed
WO-2001001957-A1 LOCAL DRUG DELIVERY BIOCOMPATIBLES LIMITED (GB) 2001-01-11 WO disclosed